Correlation Between Eton Pharmaceuticals and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Structure Therapeutics American, you can compare the effects of market volatilities on Eton Pharmaceuticals and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Structure Therapeutics.
Diversification Opportunities for Eton Pharmaceuticals and Structure Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eton and Structure is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Eton Pharmaceuticals and Structure Therapeutics
Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 0.99 times more return on investment than Structure Therapeutics. However, Eton Pharmaceuticals is 1.01 times less risky than Structure Therapeutics. It trades about 0.39 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.07 per unit of risk. If you would invest 842.00 in Eton Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 403.00 from holding Eton Pharmaceuticals or generate 47.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eton Pharmaceuticals vs. Structure Therapeutics America
Performance |
| Timeline |
| Eton Pharmaceuticals |
| Structure Therapeutics |
Eton Pharmaceuticals and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eton Pharmaceuticals and Structure Therapeutics
The main advantage of trading using opposite Eton Pharmaceuticals and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Eton Pharmaceuticals vs. Phibro Animal Health | Eton Pharmaceuticals vs. Procaps Group SA | Eton Pharmaceuticals vs. Amphastar P | Eton Pharmaceuticals vs. Alkermes Plc |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |